Genepoint Biological Technology is based in Shanghai, China. It has raised $51M in total funding. Latest round: Series D.
Genepoint Biological Technology is based in Shanghai, China. Genepoint Biological Technology has raised $51M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series D announced in January 2023. The round record for Genepoint Biological Technology runs through 2023; nothing later has been disclosed. Investors on record include LYFE Capital, Huajin Capital, Guofang Capital, Guosheng Capital, Deyi Capital, Guolian Capital. 6 distinct backers are named across the disclosed rounds.
Round data for Genepoint Biological Technology is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the companies in Shanghai and backer lists below.
Company funding database · Investor directory · Founder database · Mega-rounds 2026